This article analyzes morphometric indicators of the prostate gland and explains their diagnostic significance in benign prostatic hyperplasia, prostatitis, and prostate cancer.Imaging methods such as transrectal ultrasonography and multiparametric MRI are discussed together with digital rectal examination, laboratory testing, and histopathologic confirmation. The article also highlights measurement standardization, common sources of error, and the value of integrating quantitative morphometry with symptoms and risk stratification. Overall, accurate morphometric assessment improves diagnostic confidence, supports selection of treatment pathways, and strengthens communication among clinicians, radiologists, and pathologists.